ABSTRACT
With the goal of increasing interdisciplinary dialogue, the authors engage Dr. O’Connell’s response to “Terminal node problems: ANT 2.0 and prescription drug labels.” Specifically, the authors aim to address the questions and concerns raised by Dr. O’Connell as well as offer suggestions for future research that builds on the insights that emerge from this interdisciplinary dialectic.
Disclosure statement
No potential conflict of interest was reported by the authors.
Additional information
Funding
Notes on contributors
Molly Margaret Kessler
Molly Margaret Kessler is an assistant professor of Writing Studies at the University of Minnesota-Twin Cities. Her research areas include rhetoric of health and medicine, technical communication, and disability studies. Most recently, her research focuses on patients’ lived experiences, medical technologies, and digestive diseases and treatments. Her research has been published in Rhetoric of Health and Medicine, Journal of Health Communication, Technical Communication Quarterly, and Rhetoric Society Quarterly.
S. Scott Graham
S. Scott Graham is an assistant professor in the Department of Rhetoric & Writing at the University of Texas at Austin. He works at the intersections of computational rhetoric and science, technology, and medicine studies. He is the author of The Politics of Pain Medicine (University of Chicago Press) as well as numerous articles in journals including Rhetoric Society Quarterly, Technical Communication Quarterly, Rhetoric of Health and Medicine, and the Annals of Internal Medicine. Graham is also the developer and curator of conflictmetrics.com, a biomedical research funding visualization initiative.